Author

Line Conradsen Hiort

Observed names: Hiort, L. Conradsen, Hiort, L.C., Hiort, Line Conradsen, L. C. Hiort, L. Conradsen Hiort, L.-C. Hiort, Line C Hiort

Institution: Leo Pharma (Denmark)

Observed institutions: University of Copenhagen, Novo Nordisk (Denmark), Leo Pharma (Denmark)

OpenAlex ID: A5110051396

Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial

2013 · Helena W Rodbard, Virginia E Visco, et al. · The Lancet Diabetes & Endocrinology · 91

Self-rated general health among 40-year-old Danes and its association with all-cause mortality at 10-, 20-, and 29 years' follow-up

2008 · Anni Brit Sternhagen Nielsen, Volkert Siersma, et al. · Scandinavian Journal of Public Health · 57

Insulin analogues in children with Type 1 diabetes: a 52‐week randomized clinical trial

2012 · N. Thalange, A. Bereket, et al. · Diabetic Medicine · 41

Safety of Brodalumab in Plaque Psoriasis: Integrated Pooled Data from Five Clinical Trials

2022 · Kristian Reich, Diamant Thaçi, et al. · Acta Dermato Venereologica · 32

The impact of changes in self-rated general health on 28-year mortality among middle-aged Danes

2009 · Anni Brit Sternhagen Nielsen, Volkert Siersma, et al. · Scandinavian Journal of Primary Health Care · 26

Treatment with insulin detemir or NPH insulin in children aged 2-5 yr with type 1 diabetes mellitus

2011 · Nandu Thalange, Abdullah Bereket, et al. · Pediatric Diabetes · 20

Weight change upon once‐daily initiation of insulin detemir with or without dietary intervention in overweight or obese insulin‐naïve individuals with type 2 diabetes: results from the DIET trial

2013 · K. Niswender, M. Piletic, et al. · Diabetes Obesity and Metabolism · 15

The study of once- and twice-daily biphasic insulin aspart 30 (BIAsp 30) with sitagliptin, and twice-daily BIAsp 30 without sitagliptin, in patients with type 2 diabetes uncontrolled on sitagliptin and metformin—The Sit2Mix trial

2014 · Sultan Linjawi, Radhakrishna Sothiratnam, et al. · Primary care diabetes · 14

Development of Insulin Detemir/Insulin Aspart Cross-Reacting Antibodies Following Treatment with Insulin Detemir: 104-week Study in Children and Adolescents with Type 1 Diabetes Aged 2–16 Years

2016 · Nandu Thalange, Abdullah Bereket, et al. · Diabetes Therapy · 6

Delgocitinib cream for adolescents with moderate to severe chronic hand eczema (DELTA TEEN): a multicentre, double-blind, phase 3 randomised controlled trial

2026 · Sonja Molin, Eulalia Baselga, et al. · The Lancet Child & Adolescent Health · 3

Intensification of Basal Insulin Therapy with Step-Wise Addition of Insulin Aspart Boluses vs. Basal-Bolus Therapy: The FullSTEP™ Study

2013 · Helena W. Rodbard, Virginia E. Visco, et al. · Canadian Journal of Diabetes · 2

73148 The DELTA TEEN Phase 3 trial: systemic exposure and safety profile of delgocitinib cream in adolescents with moderate to severe Chronic Hand Eczema

2026 · Sonja Molin, Eulalia Baselga, et al. · Journal of the American Academy of Dermatology

Comparaison d’une intensification de l’insulinothérapie par l’ajout progressif de bolus prandiaux d’insuline asparte par rapport au schéma basal-bolus : résultats de l’étude FullSTEP, un essai clinique randomisé de phase IV en titration forcée

2017 · H.-W. Rodbard, V.-E. Visco, et al. · Médecine des Maladies Métaboliques

Works count: 21

Citation count: 307

H-index: 8

I10-index: 8